| ID: | 14 | |
|---|---|---|
| Name: | Compound 14 | |
| Description: | Original numeration in publication: 9h | |
| Labels: | Test_set, Benzoxazole/benzothiazole | |
| CAS: | ||
| InChi Code: | InChI=1S/C20H15N3O4S2/c1-27-13-8-6-12(7-9-13)10-16-18(25)23(20(26)29-16)11-17(24)22-19-21-14-4-2-3-5-15(14)28-19/h2-10H,11H2,1H3,(H,21,22,24)/b16-10- |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.68 |
El-Helby, A.-G. A.; Sakr, H.; Eissa, I. H. a. A.-K., A. A.; El-Adl, K. Benzoxazole/benzothiazole-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations. Arch. Pharm. (Weinheim) 2019, 352, e1900178. https://doi.org/10.1002/ardp.201900178 |
| 6.69691 |
Eq1: VEGFR-2 inhibition (Data used to validate model) |